Clinical Trial Update: A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combinations of 2 Anti-malarial Drugs (Asia) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing three-drug combinations versus two-drug combinations for uncomplicated Plasmodium falciparum malaria, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria Uncomplicated

Snippet

Sponsor: University of Oxford | Conditions: Plasmodium Falciparum Malaria (Uncomplicated) | Phase 3 | Status: COMPLETED